Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction
NCT04695600Phase 3Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2023
- Primary completion
- Aug 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in dysphagia, Cricopharyngeal dysfunction, sponsored by AIIMS New Delhi. Started Aug 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
dysphagiaCricopharyngeal dysfunction
Beyond the preview
Go deeper on NCT04695600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04695600.